Selected research
Industry Growth & Trends
Global Lansoprazole for Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Lansoprazole for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Lansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Lansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lansoprazole for Injection include Maya Biotech, Chengdu Baiyu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Luoxin Pharmaceutical, Takeda and Yuekang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Lansoprazole for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Lansoprazole for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lansoprazole for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lansoprazole for Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Lansoprazole for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Lansoprazole for Injection Market by Company
Maya Biotech
Chengdu Baiyu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Luoxin Pharmaceutical
Takeda
Yuekang Pharmaceutical
Lansoprazole for Injection Segment by Type
Vial Type
Ampule Type
Lansoprazole for Injection Segment by Application
Male
Female
Lansoprazole for Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lansoprazole for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Lansoprazole for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vial Type
- Ampule Type
Applications
- Male
- Female
Companies covered
- Maya Biotech
- Chengdu Baiyu Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Luoxin Pharmaceutical
- Takeda
- Yuekang Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Lansoprazole for Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Lansoprazole for Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Lansoprazole for Injection Market by Type
- 1.3.1 Vial Type
- 1.3.2 Ampule Type
- 1.4 Global Lansoprazole for Injection Market Size by Type
- 1.4.1 Global Lansoprazole for Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Lansoprazole for Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Lansoprazole for Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Lansoprazole for Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Lansoprazole for Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Lansoprazole for Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Lansoprazole for Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Lansoprazole for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Lansoprazole for Injection Industry Trends
- 2.2 Lansoprazole for Injection Industry Drivers
- 2.3 Lansoprazole for Injection Industry Opportunities and Challenges
- 2.4 Lansoprazole for Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Lansoprazole for Injection Revenue (2021-2026)
- 3.2 Global Top Players by Lansoprazole for Injection Sales (2021-2026)
- 3.3 Global Top Players by Lansoprazole for Injection Price (2021-2026)
- 3.4 Global Lansoprazole for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lansoprazole for Injection Major Company Production Sites & Headquarters
- 3.6 Global Lansoprazole for Injection Company, Product Type & Application
- 3.7 Global Lansoprazole for Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lansoprazole for Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lansoprazole for Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Lansoprazole for Injection Tier 1, Tier 2, and Tier 3
4 Lansoprazole for Injection Regional Status and Outlook
- 4.1 Global Lansoprazole for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Lansoprazole for Injection Historic Market Size by Region
- 4.2.1 Global Lansoprazole for Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Lansoprazole for Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Lansoprazole for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Lansoprazole for Injection Forecasted Market Size by Region
- 4.3.1 Global Lansoprazole for Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Lansoprazole for Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Lansoprazole for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lansoprazole for Injection by Application
- 5.1 Lansoprazole for Injection Market by Application
- 5.1.1 Male
- 5.1.2 Female
- 5.2 Global Lansoprazole for Injection Market Size by Application
- 5.2.1 Global Lansoprazole for Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Lansoprazole for Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Lansoprazole for Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Lansoprazole for Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Lansoprazole for Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Lansoprazole for Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Lansoprazole for Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Lansoprazole for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Maya Biotech
- 6.1.1 Maya Biotech Company Information
- 6.1.2 Maya Biotech Business Overview
- 6.1.3 Maya Biotech Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Maya Biotech Lansoprazole for Injection Product Portfolio
- 6.1.5 Maya Biotech Recent Developments
- 6.2 Chengdu Baiyu Pharmaceutical
- 6.2.1 Chengdu Baiyu Pharmaceutical Company Information
- 6.2.2 Chengdu Baiyu Pharmaceutical Business Overview
- 6.2.3 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Product Portfolio
- 6.2.5 Chengdu Baiyu Pharmaceutical Recent Developments
- 6.3 Jiangsu Aosaikang Pharmaceutical
- 6.3.1 Jiangsu Aosaikang Pharmaceutical Company Information
- 6.3.2 Jiangsu Aosaikang Pharmaceutical Business Overview
- 6.3.3 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Product Portfolio
- 6.3.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
- 6.4 Luoxin Pharmaceutical
- 6.4.1 Luoxin Pharmaceutical Company Information
- 6.4.2 Luoxin Pharmaceutical Business Overview
- 6.4.3 Luoxin Pharmaceutical Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Luoxin Pharmaceutical Lansoprazole for Injection Product Portfolio
- 6.4.5 Luoxin Pharmaceutical Recent Developments
- 6.5 Takeda
- 6.5.1 Takeda Company Information
- 6.5.2 Takeda Business Overview
- 6.5.3 Takeda Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Takeda Lansoprazole for Injection Product Portfolio
- 6.5.5 Takeda Recent Developments
- 6.6 Yuekang Pharmaceutical
- 6.6.1 Yuekang Pharmaceutical Company Information
- 6.6.2 Yuekang Pharmaceutical Business Overview
- 6.6.3 Yuekang Pharmaceutical Lansoprazole for Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Yuekang Pharmaceutical Lansoprazole for Injection Product Portfolio
- 6.6.5 Yuekang Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Lansoprazole for Injection Sales by Country
- 7.1.1 North America Lansoprazole for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Lansoprazole for Injection Sales by Country (2021-2026)
- 7.1.3 North America Lansoprazole for Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Lansoprazole for Injection Market Size by Country
- 7.2.1 North America Lansoprazole for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Lansoprazole for Injection Market Size by Country (2021-2026)
- 7.2.3 North America Lansoprazole for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Lansoprazole for Injection Sales by Country
- 8.1.1 Europe Lansoprazole for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Lansoprazole for Injection Sales by Country (2021-2026)
- 8.1.3 Europe Lansoprazole for Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Lansoprazole for Injection Market Size by Country
- 8.2.1 Europe Lansoprazole for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Lansoprazole for Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Lansoprazole for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Lansoprazole for Injection Sales by Country
- 9.1.1 Asia-Pacific Lansoprazole for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Lansoprazole for Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Lansoprazole for Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Lansoprazole for Injection Market Size by Country
- 9.2.1 Asia-Pacific Lansoprazole for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Lansoprazole for Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Lansoprazole for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Lansoprazole for Injection Sales by Country
- 10.1.1 South America Lansoprazole for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Lansoprazole for Injection Sales by Country (2021-2026)
- 10.1.3 South America Lansoprazole for Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Lansoprazole for Injection Market Size by Country
- 10.2.1 South America Lansoprazole for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Lansoprazole for Injection Market Size by Country (2021-2026)
- 10.2.3 South America Lansoprazole for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Lansoprazole for Injection Sales by Country
- 11.1.1 Middle East and Africa Lansoprazole for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Lansoprazole for Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Lansoprazole for Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Lansoprazole for Injection Market Size by Country
- 11.2.1 Middle East and Africa Lansoprazole for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Lansoprazole for Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Lansoprazole for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Lansoprazole for Injection Value Chain Analysis
- 12.1.1 Lansoprazole for Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Lansoprazole for Injection Production Mode & Process
- 12.2 Lansoprazole for Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Lansoprazole for Injection Distributors
- 12.2.3 Lansoprazole for Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst